Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (221-230 of 329) with videos related to

Pageof 33
Sort By:
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2020
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in MaliJosephine Brice, Mariam Sylla, Nathalie Desire, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2008
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006Anne Derache, Almoustapha-Issiaka Maiga, Ousmane Traore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2018
Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification StrategiesSidonie Lambert-Niclot, Maxime Grude, Jean-Luc Meynard, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countriesAvelin F Aghokeng, Nicole Ngo-Giang-Huong, Thu H K Huynh, et al.
Open Forum Infectious Diseases|July 12, 2021
Poppers, by Inducing HHV-8 Virion Production, Can Act as a Promoter for HHV-8 Transmission in Men Who Have Sex With MenAude Jary, Adélie Gothland, Romain Palich, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapySidonie Lambert-Niclot, Gilles Peytavin, Claudine Duvivier, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Claire Lamotte, Constance Delaugerre, et al.
The Journal of Infectious Diseases|August 20, 2021
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected PatientsRomain Palich, Elisa Teyssou, Sophie Sayon, et al.
Pageof 33

Showing results (221-230 of 329) with videos related to

Sort By:
Pageof 33
Vaccine|June 2, 2005
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094)Roland Tubiana, Guislaine Carcelain, Muriel Vray, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2020
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in MaliJosephine Brice, Mariam Sylla, Nathalie Desire, et al.
The Journal of Antimicrobial Chemotherapy|November 5, 2013
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapySlim Fourati, Philippe Flandre, Ruxandra Calin, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2008
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006Anne Derache, Almoustapha-Issiaka Maiga, Ousmane Traore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2018
Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification StrategiesSidonie Lambert-Niclot, Maxime Grude, Jean-Luc Meynard, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countriesAvelin F Aghokeng, Nicole Ngo-Giang-Huong, Thu H K Huynh, et al.
Open Forum Infectious Diseases|July 12, 2021
Poppers, by Inducing HHV-8 Virion Production, Can Act as a Promoter for HHV-8 Transmission in Men Who Have Sex With MenAude Jary, Adélie Gothland, Romain Palich, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapySidonie Lambert-Niclot, Gilles Peytavin, Claudine Duvivier, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Claire Lamotte, Constance Delaugerre, et al.
The Journal of Infectious Diseases|August 20, 2021
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected PatientsRomain Palich, Elisa Teyssou, Sophie Sayon, et al.
Pageof 33